Rakesh Dahiya
Monday, August 29, 2022
USFDA issues Form 483 with 6 observations to Cipla
The pharma
major,
Cipla
https://thehealthmaster.com/?p=40813
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment